ERBB2 and neoplasm: We further analyzed the relationship of ZNF545 methylation with clinicopathological features of breast cancer patients, including age, tumor grade, tumor size, lymph node metastasis, ER status, PR status and HER2 status, but no significant correlation was observed (Table 1).